UnknownNot Applicable

Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy

400 participantsStarted 2024-01-01

Plain-language summary

• to find the relationship between the different hematological indices including platelet indices, and blood cell ratios, to the development of LV thrombus in acute anterior STEMI patients managed by primary percutaneous coronary intervention (PPCI) , or thrombolytic therapy .

Who can participate

Age range15 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients presented to Assiut university cardiac catheterization laboratory with acute anterior STEMI and managed with PPCI or thrombolytic therapy. Exclusion Criteria: * • Patients not eligible to PPCI * Patients presented with inferior or lateral STEMI or any type of STEMI other than anterior STEMI.

What they're measuring

the relation of different hematological indices to the development of LV thrombus in acute anterior STEMI patients managed by primary percutaneous coronary intervention (PPCI) or thrombolytic therapy .

Timeframe: baseline

Trial details

NCT IDNCT06152939

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11

Contact for this trial

Al zahraa Sayed

01015692124 sayedzahraa570@gmail.com

View on ClinicalTrials.gov More Left Ventricular Thrombus trials